Event Brief
UPDATED Apr 30, 2026 at 1:03 PM ET
Apr 30, 2026 at 7:02 AM ET
Eli Lilly tops estimates, raises outlook on Zepbound
By The BriefBrief
Eli Lilly exceeded quarterly estimates and raised its full-year sales outlook as Zepbound and Mounjaro sales surged.
WHO: Eli Lilly
WHAT: Raised full-year sales outlook and adjusted profit guidance after strong Zepbound and Mounjaro sales
WHEN: Apr 30, 2026 at 6:51 AM ET
WHERE: Location not specified
WHY: No specific cause was reported.
How this story developed (showing 2 of 2 earlier reports)
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21427 of 21427
Same format. Every time.
Continue reading — sign in or create a free account with
